GB1285024A - Process of purifying insulin - Google Patents
Process of purifying insulinInfo
- Publication number
- GB1285024A GB1285024A GB1015772A GB1015772A GB1285024A GB 1285024 A GB1285024 A GB 1285024A GB 1015772 A GB1015772 A GB 1015772A GB 1015772 A GB1015772 A GB 1015772A GB 1285024 A GB1285024 A GB 1285024A
- Authority
- GB
- United Kingdom
- Prior art keywords
- water
- insulin
- column
- miscible organic
- miscible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1285024 Insulin purification NOVO TERAPEUTISK LABORATORIUM AS 29 July 1969 [9 Aug 1968] 10157/72 Divided out of 1285023 Heading A5B Commercial or crude insulin is purified by applying a water-containing solution thereof having a pH of from 6-10 to a column of an anion exchanger and eluting the column with a water/water-miscible organic solvent mixture containing 20-70% by vol. of water and a pH of 6-10, collecting the eluate fractions which show essentially a single component when analysed by polyacrylamide gel electrophoresis and recovering the insulin therefrom. Suitable water-miscible organic solvents are: dioxane, tetramethyl urea, dimethyl formamide, water-miscible ketones and alkanols (the last being preferred). The eluent also contains a buffer maintaining the pH in the range 6-10, preferably 6.5-8.5.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1015772A GB1285024A (en) | 1968-08-09 | 1968-08-09 | Process of purifying insulin |
MY7700303A MY7700303A (en) | 1968-08-09 | 1977-12-31 | Process of purifying insulin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1015772A GB1285024A (en) | 1968-08-09 | 1968-08-09 | Process of purifying insulin |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1285024A true GB1285024A (en) | 1972-08-09 |
Family
ID=9962587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1015772A Expired GB1285024A (en) | 1968-08-09 | 1968-08-09 | Process of purifying insulin |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB1285024A (en) |
MY (1) | MY7700303A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2173503A (en) * | 1985-04-12 | 1986-10-15 | Berlin Chemie Veb | Purification of insulin |
WO2000011030A2 (en) * | 1998-08-24 | 2000-03-02 | Aventis Pharma Deutschland Gmbh | Method for chromatographically purifying insulins |
WO2013048330A1 (en) * | 2011-09-30 | 2013-04-04 | Ge Healthcare Bio-Sciences Ab | Method for purification of cleaved pro-insulin |
-
1968
- 1968-08-09 GB GB1015772A patent/GB1285024A/en not_active Expired
-
1977
- 1977-12-31 MY MY7700303A patent/MY7700303A/en unknown
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2173503A (en) * | 1985-04-12 | 1986-10-15 | Berlin Chemie Veb | Purification of insulin |
WO2000011030A2 (en) * | 1998-08-24 | 2000-03-02 | Aventis Pharma Deutschland Gmbh | Method for chromatographically purifying insulins |
WO2000011030A3 (en) * | 1998-08-24 | 2000-06-02 | Aventis Pharma Gmbh | Method for chromatographically purifying insulins |
AU756105B2 (en) * | 1998-08-24 | 2003-01-02 | Sanofi-Aventis Deutschland Gmbh | Method for chromatographically purifying insulins |
US6710167B1 (en) | 1998-08-24 | 2004-03-23 | Aventis Pharma Deutschland Gmbh | Procedure for the chromatographic purification of insulins |
KR100703578B1 (en) * | 1998-08-24 | 2007-04-05 | 사노피-아벤티스 도이칠란트 게엠베하 | Method for chromatographically purifying insulins |
CZ300604B6 (en) * | 1998-08-24 | 2009-06-24 | Sanofi - Aventis Deutschland GmbH | Chromatographic purification process of insulins |
WO2013048330A1 (en) * | 2011-09-30 | 2013-04-04 | Ge Healthcare Bio-Sciences Ab | Method for purification of cleaved pro-insulin |
CN103827136A (en) * | 2011-09-30 | 2014-05-28 | 通用电气健康护理生物科学股份公司 | Method for purification of cleaved pro-insulin |
CN103827136B (en) * | 2011-09-30 | 2016-07-06 | 通用电气健康护理生物科学股份公司 | Purify the insulinogenic method of cracking |
US9409967B2 (en) | 2011-09-30 | 2016-08-09 | Ge Healthcare Bioprocess R&D Ab | Method for purification of cleaved pro-insulin |
Also Published As
Publication number | Publication date |
---|---|
MY7700303A (en) | 1977-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jacquet et al. | A thermostable protein factor acting on in vitro DNA transcription | |
Remy et al. | Purification of yeast phenylalanyl-tRNA synthetase by affinity chromatography, on a tRNAPhe-sepharose column | |
BG49497A3 (en) | Method for preparing akarboza | |
FR2348942B3 (en) | ||
EP0171765A3 (en) | A method for purification of japanese encephalitis virus | |
GB1534812A (en) | Method for the purification of interferon | |
DE3064133D1 (en) | Purification of human growth hormone | |
Nagashima et al. | Possibility that myrosinase is a single enzyme and mechanism of decomposition of mustard oil glucoside by myrosinase | |
GB1285024A (en) | Process of purifying insulin | |
GB908333A (en) | Method for the production of substantially protein-free callicrein | |
NL8501105A (en) | PROCESS FOR THE PURIFICATION OF INSULIN. | |
ATE20071T1 (en) | METHOD OF PURIFICATION OF SECRETINE. | |
ES370345A1 (en) | Improvements in or relating to injectable insulin preparations | |
Berglund et al. | [18] ATP-and dATP-substituted agaroses and the purification of ribonucleotide reductases | |
Stockx et al. | The Ribonuclease of Phaseolus Aureus Roxb: I. Purification of the Enzyme | |
US4658017A (en) | Method for the large scale purification of human fibroblast interferon | |
Iwai et al. | Histone fractions of protozoa: their correlation with mammalian histones | |
ENDO | Studies on Pectolytic Enzymes of Molds Part IX. Purification and Properties of Endo-Polygalacturonase II | |
Libor et al. | Binding behaviour of pyruvate carboxylase from Bacillus stearothermophilus on Sepharose—avidin | |
GB1341574A (en) | ||
JPS5231021A (en) | Process for purification of crude n-omega-long-chain acyl basic amino acid or its metal salt | |
GB1133071A (en) | Highly purified gonadotropins and process for the manufacture thereof | |
SU437766A1 (en) | Method for isolating ribomononucleotides | |
Wilchek et al. | [57] Purification of nucleases | |
FR2299313A1 (en) | Purification of insulin by gel filtration - using an alkali metal or ammonium insulin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
416 | Proceeding under section 16 patents act 1949 | ||
414F | Notice of opposition given (sect. 14/1949) | ||
414B | Case decided by the comptroller ** grants allowed (sect. 14/1949) | ||
4145 | Application made to the patents appeal tribunal (sect. 14/1949) | ||
414L | Case decided on appeal ** grant allowed (sect. 14/1949) | ||
PS | Patent sealed | ||
429A | Application made for amendment of specification (sect. 29/1949) | ||
429H | Application (made) for amendment of specification now open to opposition (sect. 29/1949) | ||
429D | Case decided by the comptroller ** specification amended (sect. 29/1949) | ||
SP | Amendment (slips) printed | ||
PCNP | Patent ceased through non-payment of renewal fee |